Ticker
CDTCompany Name
CONDUIT PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 5.11M | $ 15.17M | $ 292K | $ 0 | -302.37% |
3/31/2025 | $ 4.88M | $ 11.5M | $ 316K | $ 0 | -242.16% |
12/31/2024 | $ 5.93M | $ 3.44M | $ 2.45M | $ 0 | -99.34% |
9/30/2024 | $ 9.66M | $ -386K | $ 1.75M | $ 0 | -14.1% |
6/30/2024 | $ 16.32M | $ 8.26M | $ 55K | $ 0 | -50.97% |
3/31/2024 | $ 209.66M | $ 8.64M | $ 66K | $ 0 | -4.15% |
12/31/2023 | $ 228.12M | $ 8.64M | $ 2.29M | $ 0 | -4.79% |
9/30/2023 | $ 93.2M | $ -130.65M | $ 3.57M | $ 0 | 136.35% |
6/30/2023 | $ 126.7M | $ -139.3M | $ 3.52M | $ 0 | 107.17% |
3/31/2023 | $ 65.61M | $ -113.83M | $ 300K | $ 0 | 173.03% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for CONDUIT PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 172.57M ]
(=) Shareholder Yield [ 0% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |